IMMUNIZATION
&
COLD CHAIN
GAJJAR PRASHANT
ROLL NO.-36
IMMUNIZATION
Immunization is defined as the procedure by which
the body is prepared to fight against a specific
disease.
Immunization is of two types:
1. Passive immunization
2. Active immunization.
„ PASSIVE IMMUNIZATION
Passive immunization or immunity is produced without
challenging the immune system of the body.
done by administration of serum or gamma globulins from
a person who is already immunized (affected by the
disease) to a non-immune person.
Passive immunization is acquired either naturally or
artificially.
It is developed by injecting previously prepared
antibodies using serum from humans or animals.
This type of immunity is useful for providing
immediate protection against acute infections like
tetanus, measles, etc.
ACTIVE IMMUNIZATION
Active immunization or immunity is acquired by
activating immune system of the body.
Body develops resistance against disease by
producing antibodies following the exposure to
antigens.
 Active immunity is acquire
Naturally
Artificially
Active Natural Immunization
Naturally acquired active immunity involves activation of immune
system in the body to produce antibodies against microorganism.
 It is achieved in both clinical and subclinical infections
Active Artificial Immunization
It is achieved by the administration of vaccines
or toxoids.
Herd Immunity
It is a type of immunity that occurs when the vaccination
of a portion of population provides protection to
unprotected individual.
The higher the number of immune individuals, the lower
the like hood that a susceptible people will come in contact
with an infectious agent.
Resistance to spread of infectious disease in a group
because of few susceptible members, making transmission
unlikely.
Immunization & cold chain
Vaccine
9
Vaccine is a substance that is introduced into the
body to prevent the disease produced by certain
pathogens.
It consists of dead pathogens or live but attenuated
(artificially weakened) organisms.
The vaccine induces immunity against the pathogen,
either by production of antibodies or by activation of T
lymphocytes.
Types of vaccine
A. Live-attenuated (weakened)
vaccines:
contain modified strains of a pathogen (bacteria or viruses)
that have been weakened but are able to multiply within the
body and remain antigenic enough to induce a strong
immune response.
B.Killed-inactivated vaccines:
To produce this type of vaccines, bacteria or viruses are
killed or inactivated by a chemical treatment or heat. 10
C.Sub-unit vaccines
Subunit vaccines include only the antigens that best
stimulate the immune system.
In some cases, epitopes are used—the very specific parts of
the antigen that antibodies or T cells recognize and bind
to.
Subunit vaccines contain only the essential antigens and
not all the other molecules that make up the microbe, the
chances of adverse reactions to the vaccine are lower.
11
Types of subunit vaccines;-
1.toxoids
2.protein vaccine
3.recombinant protein vaccine
4.polysaccharide based vaccine
5.conjugated vaccine
D. Combination
If more than one kind of immunising agent is included in
the vaccine it is called a mixed or combined vaccine.
The advantage of combined vaccine is as below:
1.simplify administration
2.reduce cost
3.improving timeline of vaccination
4.reducing the storage
13
•Example of mixed vaccines are DPT,DT,DP,MMR,etc.
•POLYVALENT: It is prepared from 2 or more strain of the
same species
vaccine Example
Live, attenuated
Measles, mumps, rubella (MMR combined
vaccine)
Varicella (chickenpox)
Influenza (nasal spray)
Rotavirus
Inactivated/Killed
Polio (IPV)
Hepatitis A 15
Combined DPT,TT
Subunit/conjugate
Hepatitis B
Influenza (injection)
Homophiles influenza type b (Hib)
Pertussis, Diphtheria, tetanus
Why Immunization ?
Key strategy to child survival
Protecting infants from diseases.
Lowers morbidity and mortality rates in children.
Indicator of a strong primary health care system.
17
History of
Immunization
18
Edward Jenner Vaccinating
19
Beginning of Vaccination.
Vaccination (Latin ;
Vacca- Cow )
 Edward Jenner used
the term Vaccination
 Cow pox virus
provided immunity in
prevention of Small
pox 20
14 May 1796 - Jenner inoculated James Phipps, an 8 yr old
boy.
Boy recovered after a brief illness
Jenner inoculated pus taken from a small pox patient.
Boy showed no reaction.
Jenner recommended vaccination for prevention of
smallpox
Small pox eradicated in 1977.
WHO certified India to be free of smallpox in march 1977.21
SMALL POX
22
1978: Expanded Program of Immunization (EPI)
introduced after smallpox eradication: BCG, DPT,
OPV, Typhoid.
Limited to mainly urban areas
23
1985 : Universal Immunization Program (UIP)
introduced; Expanded to entire country; Measles
added.
1990 : Vitamin-A supplementation.
1992: Child Survival and Safe Motherhood Program.
1995: Polio National Immunization Days.
1997: Reproductive and Child Health Program (RCH
I).
2005 : RCH-II and the National Rural Health Mission
EPI
Adding more disease controlling antigens to vaccination
schedules.
Extending coverage to all corners of a country.
Spreading services to reach the less privileged sectors of
the society
EPI is developed to protect all
children of the world against 6
vaccine preventable diseases
Diphtheria
Tetanus
Polio
Tuberculosis
Measles
Pertussis (whooping cough)
1985 – UNICEF re named it as “UNIVERSAL
IMMUNIZATION PROGRAMME”.
There is no difference between both the programme.
Universal immunization programme
&
National immunization programme
EPI IN INDIA 1978
The Govt. of India launched it’s EPI in 1978.
The objective was to reducing mortality, morbidity
resulting from VPDs.
To achieve a self sufficiency in vaccine production.
COMPONENTS OF UIP
1. Immunization of pregnant women against tetanus.
2.Immunization of children in their first year of life
against 6 VPDs.
3. The aim was to achieve 100 % coverage of pregnant
women with 2 doses of TT & at least 85% coverage
of children under one year (with 3 doses of DPT,
OPV & one dose of BCG, One dose of MMR) by 1990
TWO COMPONENTS OF UIP
OBJECTIVES
To increase immunization coverage.
To improve quality of service.
To achieve self sufficiency in vaccine production
To train health personnel
To supply cold chain equipment and establish a
good surveillance network.
To ensure district wise monitoring
Accelerate control of vaccine-
preventable diseases
Strengthen routine
immunization to meet
vaccination coverage targets
Introduce new and improved
vaccines
Spur research and
development for the next
generation of vaccines and
technologies
Objectives of
WHO in
immunization
“NO CHILD
SHOULD BE
DENIED OF
IMMUNIZATION.”
STATUS OF VPD -INDIA
Disease 1987 2011 %
declin
e
POLIMYELI
TIS
28,257 1 100
DIPTHERI
A
12,952 4,233 62.3
PERTUSIS 163,786 3,909 76.13
MEASLES 247,519 33,634 86.41
NATIONAL IMMUNIZAION
SCHEDULE
VACCIN
E
When to give Does Route Site
TT-1 Early in pregnancy 0.5ml Intra-
muscula
r
Upper
arm
TT-2 4 weeks after TT-1 0.5ml Intra-
muscula
r
Upper
arm
TT-
booster
If received 2 TT
doses in a pregnancy
within the last 3
0.5ml Intra-
muscula
r
Upper
arm
FOR INFANT
VACCINE When to give Doe
s
Route Site
BCG At birth or early as
possible till 1 year of age
0.1 ml Intra-
dermal
Left upper
arm
Hepatitis B At birth or early as
possible within 24 hour
0.5ml IM Antero-lateral
side of mid
thigh
OPV-0 At birth or early as
possible within the 1st 15
days
2 drops Oral Oral
OPV-1,2&3 At 6,10,&14 weeks 2 drops Oral Oral
DPT-1,2&3 At 6,10,&14 weeks 0.5ml IM Antero-lateral
side of mid
thigh
Hepatitis B
1,2&3
At 6,10,&14 weeks 0.5ml IM Antero-lateral
side of mid
thigh
Measles 9 completed months-12 0.5ml Sub- Right upper
 For children
DPT booster 16-24 months 0.5ml IM Antero-lateral
side of mid
thigh
OPV booster 16-24 months 2
drops
ORAL ORAL
Measles 16-24 months 0.5ml Sub-
cutaneous
Right upper
arm
JE 16-24 months with
DPT/OPV booster
0.5 ml Sub-
cutaneous
Left upper arm
Vitamin A 16 months with DPT/OPV
booster. Than 1 does every 6
months up to age of 5 years
2ml(2
lakh
IU)
Oral Oral
DPT BOOSTER 5-6 years 0.5ml IM Upper arm
TT 10 year &16 year 0.5ml IM Upper arm
Vaccines under UIP
Under UIP, following vaccines are provided:
1. BCG (Bacillus Calmette Guerin)
2. DPT (Diphtheria, Pertussis and Tetanus Toxoid)
3. OPV (Oral Polio Vaccine)
4. Measles
5. Hepatitis B
6. TT (Tetanus Toxoid)
7. JE vaccination (in selected high disease burden
districts)
8. Hib containing Pentavalent vaccine
(DPT+HepB+Hib) (In selected States)
Diseases covered under
UIP
1. Diphtheria
2. Pertussis.
3. Tetanus
4. Polio
5. Tuberculosis
6. Measles
7. Hepatitis B
8. Japanese Encephalitis ( commonly known as brain
fever)
9. Meningitis and Pneumonia caused by Haemophilus
Influenzae type b
Barriers to Immunization
Physical barriers
-Waiting time
-Distance
-Discomfort
Psychological barriers
-Discourtesy
- Endangered privacy
Reasons for Low Immunization
Coverage
 Failure to provide immunization
 Un-reached populations:-
- Unawareness
- socio-economic barriers
- geographic access
 Resistant populations
 Missed Opportunities
 Improper logistics management
What Should not Hold Routine
Immunization
 Minor illnesses such as upper respiratory infections
or diarrhea, mild fever (< 38.5°c)
Allergy, asthma
Prematurity, underweight newborn child
 Family history of convulsions
Treatment with antibiotics
 Dermatosis, eczema or localized skin infection
 Chronic diseases of the heart, lung, kidney and liver.
 Stable neurological conditions, such as cerebral palsy and
Down's syndrome
 History of jaundice after birth
Immunization & cold chain
COLDCHAIN
Cold Chain
The ‘cold chain’ is the system of
transporting and storing vaccines at
recommended temperature from the
point of manufacture to the point of
use.
Manufacturer
Distributor
Vaccine
Depots
Provider
office
Client
Why is the cold chain important ?
1. Vaccines are:
 Biological products
 lose potency with time
 Process irreversible and accelerated if
proper storage conditions are not
adhered to.
2. Assurance in potent product
and vaccine programmes
 Professional responsibility
 Confident the vaccines you give
will be effective
 Public Health responsibility
 Public confidence in immunisation
programmes
3. Ensuring maximum benefit
from immunisations
Responsibility not to waste scarce NHS
resources
Reduce wastage from errors
4.Compliance with
SPC/Manufacturer
Any vaccine that has not been stored at
a temperature of 2-8ºC as per its
licensing conditions is no longer a
licensed product
Cold chain storage equipment
Walk in cold
rooms
Deep freezers Ice lined
refrigerators
A. Walk in cold rooms(WIC)
At regional level
Storage up to 3 months
Serve 4-5 districts
B. Deep freezers
 At district & PHC levels
 Temp :- -15oc to -25oc
 At PHC, used only for the preparation of
ice packs
 In case of power failure these freezers
can maintain the cabinet temp. for 18-22
hours
 20-25 icepack can be prepared by a 140L
in deep freezers with continuous electric
supply of 8 hours.
C. Ice Lined Refrigerators(ILR)
 Both at district and PHC levels
 Temp :- +2oc to +8oc
 ILR’s are top opening, can hold
cold air inside better than
front opening refrigerators
 It can keep vaccine safe with 8
hours of continuous electric
supply in a 24 hours period.
Arrangement of vaccine order top to bottom:
Hepatitis B
DPT & TT
BCG
Measles
OPV
Discard any frozen hep.b, DPT, & TT.
Keep spaces between boxes
Measles & OPV can be kept over 2 rows of empty ice-packs on the
floor of the ILR.
Vaccine Stability
 Sensitivity to
HEAT
OPV
Measles
BCG
MMR
Hepatitis B
DT
 Sensitivity to COLD
HepB and
combination
Influenza
*BCG
(*Freeze dried)
MOST SENSITIVE
Temperature must be
recorded twice in a day
with dial thermometer
LEAST SENSITIVE
Light Sensitive
Sensitive to strong light, sunlight, ultraviolet,
fluorescents (neon)
OPV
Measles
MMR
Varicella
Meningococcal C Conjugate
Most DTaP containing vaccines
Vaccines should
always be stored in
their original
packaging until point
of use to protect them
from light
Vaccine Storage
 Use a dedicated vaccine
fridge
 Safeguard electricity supply
 No more than 50% full
 Place vaccines in clearly
labelled plastic mesh
baskets
 Group vaccines by type
(Paediatric, Adult,
Adolescent)
 Defrost/calibrate fridge
regularly
X No food or medical
specimens
X Do not place fridge in
direct sunlight or near heat
source
X Do not store vaccines for
more than 1 month at PHC.
X Do not store vaccines in
fridge doors or in solid
plastic trays/containers
within the fridge
X Keep vaccines away from
fridge walls and cold air
vents
Picture taken from www.medisave.co.uk
DO’sDON’T’s
Transporting Equipment
Cold
boxes
Vaccine
carriers
Day
carriers
Used for transport of vaccines
Fully frozen ice packs placed at the
bottom and sides
DPT, TT, DT should not be kept in
direct contact
1.Cold boxes
Used to carry small quantity of
vaccines(16 to 20 vials)
For out of reach sessions
4 icepacks are used
2.Vaccine
carriers
3.Day carriers
Used to carry very small quantities of
vaccines(6 to 8 vials)
For a near by session
2 icepacks are used
For only 2 hours period
ICE PACKS
It contains water & no salt shold be added to it.
The water should be filled upto the level marked on
the side.
If there is leakage such icepack should be discarded.
Vaccine Vial Monitor(VVM)
VVM is a label containing heat sensitive
material that is placed on a vaccine vial
to register heat exposure over time
Vaccine vial
monitor
Stage 1
• Inner square
lighter than
outer circle
Stage 2
• Inner square
still lighter than
outer circle
Stage 3
• Color of inner
square matches
the outer circle
Stage 4
• Color of inner
square darker
than outer circle
Combined effects of time and temperature
cause the inner square to darken gradually and
irreversibly
VVM does not directly measure the vaccine
potency but gives info about the main factor that
affects potency
Immunization & cold chain
Immunization & cold chain
Mission Indradhanush
Mission Indradhanush was launched by
Ministry of Health and Family Welfare
(MOHFW) Government of India on 25th
December, 2014. The objective of this mission is
to ensure that all children under the age of two
years as well as pregnant women are fully
immunized with seven vaccine preventable
diseases.
The Mission Indradhanush, depicting seven colours of the
rainbow, targets to immunize all children against seven
vaccine preventable diseases.
Immunization & cold chain
Science Hopes a Vaccine for
every Disease
Vaccination created HOPE
in Humanity
Immunization & cold chain

More Related Content

PPTX
MISSION INDRADHANUSH.pptx
PPTX
Child rrestraints
PPTX
Cold chain ppt
PPTX
breast self examination
PPTX
Pediatric mcq
PPTX
High risk newborn
PPTX
Cold chain
MISSION INDRADHANUSH.pptx
Child rrestraints
Cold chain ppt
breast self examination
Pediatric mcq
High risk newborn
Cold chain

What's hot (20)

PPTX
Hospital environment for a sick child
PPTX
IMMUNIZATION SCHEDULE
PPT
LOW BIRTH WEIGHT BABY
PPT
Immunization in children
PPTX
Vaccines in children
PPTX
Immunization schedule
PPTX
CHILD GUIDANCE CLINIC. PPT.pptx
PPTX
ARTIFICIAL FEEDING.pptx
PPTX
hiv aids in children
PDF
Immunization
PPT
internationally accepted rights of the children
PPTX
Immunization and Cold Chain
PPTX
Immunization or vaccination of children
PDF
IMNCI (Integrated Management of Neonatal and Childhood Illness)
PPTX
Immunization
PPTX
National immunization schedule
PDF
PPTX
HOSPITALIZATION: Effect on children and their parents
PDF
Under five clinic and well baby clinic
Hospital environment for a sick child
IMMUNIZATION SCHEDULE
LOW BIRTH WEIGHT BABY
Immunization in children
Vaccines in children
Immunization schedule
CHILD GUIDANCE CLINIC. PPT.pptx
ARTIFICIAL FEEDING.pptx
hiv aids in children
Immunization
internationally accepted rights of the children
Immunization and Cold Chain
Immunization or vaccination of children
IMNCI (Integrated Management of Neonatal and Childhood Illness)
Immunization
National immunization schedule
HOSPITALIZATION: Effect on children and their parents
Under five clinic and well baby clinic
Ad

Viewers also liked (20)

PDF
Universal Immunization Programme
PPTX
Cold chain
PPTX
Vaccines
PPT
Cold chain equipment
PPT
Cold chain system for vaccines
PPT
The Cold Chain
PPTX
NATIONAL IMMUNISATION PROGRAMME ...
PDF
Immunization
PPTX
Vaccination ppt
PDF
Cold chain tot
PPT
BASICS-N PROJECT Community Partners for Health (CPH) Coalitions in Lagos, Nig...
 
PPTX
Immunization in adults, geriatrics and paediatrics.
PPT
Npi
PPTX
World Immunization Week 2016
PPT
Recommended Immunization Schedules For Children And Adolescents,
PPTX
immunization
PDF
Vaccine Stock Management Tool - System documentation
PPT
Immunization against childhood killer diseases
PPT
Malaysian immunization
Universal Immunization Programme
Cold chain
Vaccines
Cold chain equipment
Cold chain system for vaccines
The Cold Chain
NATIONAL IMMUNISATION PROGRAMME ...
Immunization
Vaccination ppt
Cold chain tot
BASICS-N PROJECT Community Partners for Health (CPH) Coalitions in Lagos, Nig...
 
Immunization in adults, geriatrics and paediatrics.
Npi
World Immunization Week 2016
Recommended Immunization Schedules For Children And Adolescents,
immunization
Vaccine Stock Management Tool - System documentation
Immunization against childhood killer diseases
Malaysian immunization
Ad

Similar to Immunization & cold chain (20)

PPTX
Epi seminar
PPTX
Immunisation programme.pptx
PPTX
Immunisation programme & national Immunisation schedulepptx
PPT
04 -immunization
PPTX
Immunization Pediatrics Presentation .pptx
PPT
Immunity and vaccine (community medicine )
PPTX
IMMUNIZATION.pptx
PPTX
community health nursing.pptx
PPTX
Tropical Diseases By Mumtaz Ali Khan .pptx
PPTX
vaccination in infants pediatrics topic 1.pptx
PPTX
Immunity and its Types.pptx (Mumtaz Ali Khan
PPTX
Vaccine &amp; vaccination
PPTX
Tropical Diseases and Immunization & TD.pptx
PPTX
David Haselwood | How vaccines prevent diseases
PPT
Vaccination
PPTX
vaccines-191201151736.pptx
DOCX
immunization.docx
PPTX
Vaccinations - Basics
PDF
EPI ( Expanded program on immunization)
Epi seminar
Immunisation programme.pptx
Immunisation programme & national Immunisation schedulepptx
04 -immunization
Immunization Pediatrics Presentation .pptx
Immunity and vaccine (community medicine )
IMMUNIZATION.pptx
community health nursing.pptx
Tropical Diseases By Mumtaz Ali Khan .pptx
vaccination in infants pediatrics topic 1.pptx
Immunity and its Types.pptx (Mumtaz Ali Khan
Vaccine &amp; vaccination
Tropical Diseases and Immunization & TD.pptx
David Haselwood | How vaccines prevent diseases
Vaccination
vaccines-191201151736.pptx
immunization.docx
Vaccinations - Basics
EPI ( Expanded program on immunization)

Recently uploaded (20)

PPTX
Nancy Caroline Emergency Paramedic Chapter 7
PPTX
Arthritis Types, Signs & Treatment with physiotherapy management
PDF
Essentials of Hysteroscopy at World Laparoscopy Hospital
PDF
demography and familyplanning-181222172149.pdf
DOCX
PT10 continues to explose your mind right after reading
PPTX
POSTURE.pptx......,............. .........
PDF
chapter 14.pdf Ch+12+SGOB.docx hilighted important stuff on exa,
PDF
ENT MedMap you can study for the exam with this.pdf
PDF
Zuri Health Pan-African Digital Health Innovator.pdf
PDF
Medical_Biology_and_Genetics_Current_Studies_I.pdf
PPTX
HIGHLIGHTS of NDCT 2019 WITH IMPACT ON CLINICAL RESEARCH.pptx
PPTX
GCP GUIDELINES 2025 mmch workshop .pptx
PDF
health promotion and maintenance of elderly
PPTX
Nancy Caroline Emergency Paramedic Chapter 4
PDF
Back node with known primary managementt
PDF
Fundamentals Final Review Questions.docx.pdf
PPTX
Fever and skin rash - Approach.pptxBy Dr Gururaja R , Paediatrician. An usef...
PDF
01. Histology New Classification of histo is clear calssification
PPTX
Acute renal failure.pptx for BNs 2nd year
PPTX
OSTEOMYELITIS and OSTEORADIONECROSIS.pptx
Nancy Caroline Emergency Paramedic Chapter 7
Arthritis Types, Signs & Treatment with physiotherapy management
Essentials of Hysteroscopy at World Laparoscopy Hospital
demography and familyplanning-181222172149.pdf
PT10 continues to explose your mind right after reading
POSTURE.pptx......,............. .........
chapter 14.pdf Ch+12+SGOB.docx hilighted important stuff on exa,
ENT MedMap you can study for the exam with this.pdf
Zuri Health Pan-African Digital Health Innovator.pdf
Medical_Biology_and_Genetics_Current_Studies_I.pdf
HIGHLIGHTS of NDCT 2019 WITH IMPACT ON CLINICAL RESEARCH.pptx
GCP GUIDELINES 2025 mmch workshop .pptx
health promotion and maintenance of elderly
Nancy Caroline Emergency Paramedic Chapter 4
Back node with known primary managementt
Fundamentals Final Review Questions.docx.pdf
Fever and skin rash - Approach.pptxBy Dr Gururaja R , Paediatrician. An usef...
01. Histology New Classification of histo is clear calssification
Acute renal failure.pptx for BNs 2nd year
OSTEOMYELITIS and OSTEORADIONECROSIS.pptx

Immunization & cold chain

  • 2. IMMUNIZATION Immunization is defined as the procedure by which the body is prepared to fight against a specific disease. Immunization is of two types: 1. Passive immunization 2. Active immunization.
  • 3. „ PASSIVE IMMUNIZATION Passive immunization or immunity is produced without challenging the immune system of the body. done by administration of serum or gamma globulins from a person who is already immunized (affected by the disease) to a non-immune person. Passive immunization is acquired either naturally or artificially.
  • 4. It is developed by injecting previously prepared antibodies using serum from humans or animals. This type of immunity is useful for providing immediate protection against acute infections like tetanus, measles, etc.
  • 5. ACTIVE IMMUNIZATION Active immunization or immunity is acquired by activating immune system of the body. Body develops resistance against disease by producing antibodies following the exposure to antigens.  Active immunity is acquire Naturally Artificially
  • 6. Active Natural Immunization Naturally acquired active immunity involves activation of immune system in the body to produce antibodies against microorganism.  It is achieved in both clinical and subclinical infections Active Artificial Immunization It is achieved by the administration of vaccines or toxoids.
  • 7. Herd Immunity It is a type of immunity that occurs when the vaccination of a portion of population provides protection to unprotected individual. The higher the number of immune individuals, the lower the like hood that a susceptible people will come in contact with an infectious agent. Resistance to spread of infectious disease in a group because of few susceptible members, making transmission unlikely.
  • 9. Vaccine 9 Vaccine is a substance that is introduced into the body to prevent the disease produced by certain pathogens. It consists of dead pathogens or live but attenuated (artificially weakened) organisms. The vaccine induces immunity against the pathogen, either by production of antibodies or by activation of T lymphocytes.
  • 10. Types of vaccine A. Live-attenuated (weakened) vaccines: contain modified strains of a pathogen (bacteria or viruses) that have been weakened but are able to multiply within the body and remain antigenic enough to induce a strong immune response. B.Killed-inactivated vaccines: To produce this type of vaccines, bacteria or viruses are killed or inactivated by a chemical treatment or heat. 10
  • 11. C.Sub-unit vaccines Subunit vaccines include only the antigens that best stimulate the immune system. In some cases, epitopes are used—the very specific parts of the antigen that antibodies or T cells recognize and bind to. Subunit vaccines contain only the essential antigens and not all the other molecules that make up the microbe, the chances of adverse reactions to the vaccine are lower. 11
  • 12. Types of subunit vaccines;- 1.toxoids 2.protein vaccine 3.recombinant protein vaccine 4.polysaccharide based vaccine 5.conjugated vaccine
  • 13. D. Combination If more than one kind of immunising agent is included in the vaccine it is called a mixed or combined vaccine. The advantage of combined vaccine is as below: 1.simplify administration 2.reduce cost 3.improving timeline of vaccination 4.reducing the storage 13
  • 14. •Example of mixed vaccines are DPT,DT,DP,MMR,etc. •POLYVALENT: It is prepared from 2 or more strain of the same species
  • 15. vaccine Example Live, attenuated Measles, mumps, rubella (MMR combined vaccine) Varicella (chickenpox) Influenza (nasal spray) Rotavirus Inactivated/Killed Polio (IPV) Hepatitis A 15
  • 16. Combined DPT,TT Subunit/conjugate Hepatitis B Influenza (injection) Homophiles influenza type b (Hib) Pertussis, Diphtheria, tetanus
  • 17. Why Immunization ? Key strategy to child survival Protecting infants from diseases. Lowers morbidity and mortality rates in children. Indicator of a strong primary health care system. 17
  • 20. Beginning of Vaccination. Vaccination (Latin ; Vacca- Cow )  Edward Jenner used the term Vaccination  Cow pox virus provided immunity in prevention of Small pox 20
  • 21. 14 May 1796 - Jenner inoculated James Phipps, an 8 yr old boy. Boy recovered after a brief illness Jenner inoculated pus taken from a small pox patient. Boy showed no reaction. Jenner recommended vaccination for prevention of smallpox Small pox eradicated in 1977. WHO certified India to be free of smallpox in march 1977.21
  • 23. 1978: Expanded Program of Immunization (EPI) introduced after smallpox eradication: BCG, DPT, OPV, Typhoid. Limited to mainly urban areas 23
  • 24. 1985 : Universal Immunization Program (UIP) introduced; Expanded to entire country; Measles added. 1990 : Vitamin-A supplementation. 1992: Child Survival and Safe Motherhood Program. 1995: Polio National Immunization Days. 1997: Reproductive and Child Health Program (RCH I). 2005 : RCH-II and the National Rural Health Mission
  • 25. EPI Adding more disease controlling antigens to vaccination schedules. Extending coverage to all corners of a country. Spreading services to reach the less privileged sectors of the society
  • 26. EPI is developed to protect all children of the world against 6 vaccine preventable diseases Diphtheria Tetanus Polio Tuberculosis Measles Pertussis (whooping cough)
  • 27. 1985 – UNICEF re named it as “UNIVERSAL IMMUNIZATION PROGRAMME”. There is no difference between both the programme.
  • 29. EPI IN INDIA 1978 The Govt. of India launched it’s EPI in 1978. The objective was to reducing mortality, morbidity resulting from VPDs. To achieve a self sufficiency in vaccine production.
  • 30. COMPONENTS OF UIP 1. Immunization of pregnant women against tetanus. 2.Immunization of children in their first year of life against 6 VPDs. 3. The aim was to achieve 100 % coverage of pregnant women with 2 doses of TT & at least 85% coverage of children under one year (with 3 doses of DPT, OPV & one dose of BCG, One dose of MMR) by 1990
  • 32. OBJECTIVES To increase immunization coverage. To improve quality of service. To achieve self sufficiency in vaccine production To train health personnel To supply cold chain equipment and establish a good surveillance network. To ensure district wise monitoring
  • 33. Accelerate control of vaccine- preventable diseases Strengthen routine immunization to meet vaccination coverage targets Introduce new and improved vaccines Spur research and development for the next generation of vaccines and technologies Objectives of WHO in immunization
  • 34. “NO CHILD SHOULD BE DENIED OF IMMUNIZATION.”
  • 35. STATUS OF VPD -INDIA Disease 1987 2011 % declin e POLIMYELI TIS 28,257 1 100 DIPTHERI A 12,952 4,233 62.3 PERTUSIS 163,786 3,909 76.13 MEASLES 247,519 33,634 86.41
  • 36. NATIONAL IMMUNIZAION SCHEDULE VACCIN E When to give Does Route Site TT-1 Early in pregnancy 0.5ml Intra- muscula r Upper arm TT-2 4 weeks after TT-1 0.5ml Intra- muscula r Upper arm TT- booster If received 2 TT doses in a pregnancy within the last 3 0.5ml Intra- muscula r Upper arm
  • 37. FOR INFANT VACCINE When to give Doe s Route Site BCG At birth or early as possible till 1 year of age 0.1 ml Intra- dermal Left upper arm Hepatitis B At birth or early as possible within 24 hour 0.5ml IM Antero-lateral side of mid thigh OPV-0 At birth or early as possible within the 1st 15 days 2 drops Oral Oral OPV-1,2&3 At 6,10,&14 weeks 2 drops Oral Oral DPT-1,2&3 At 6,10,&14 weeks 0.5ml IM Antero-lateral side of mid thigh Hepatitis B 1,2&3 At 6,10,&14 weeks 0.5ml IM Antero-lateral side of mid thigh Measles 9 completed months-12 0.5ml Sub- Right upper
  • 38.  For children DPT booster 16-24 months 0.5ml IM Antero-lateral side of mid thigh OPV booster 16-24 months 2 drops ORAL ORAL Measles 16-24 months 0.5ml Sub- cutaneous Right upper arm JE 16-24 months with DPT/OPV booster 0.5 ml Sub- cutaneous Left upper arm Vitamin A 16 months with DPT/OPV booster. Than 1 does every 6 months up to age of 5 years 2ml(2 lakh IU) Oral Oral DPT BOOSTER 5-6 years 0.5ml IM Upper arm TT 10 year &16 year 0.5ml IM Upper arm
  • 39. Vaccines under UIP Under UIP, following vaccines are provided: 1. BCG (Bacillus Calmette Guerin) 2. DPT (Diphtheria, Pertussis and Tetanus Toxoid) 3. OPV (Oral Polio Vaccine) 4. Measles
  • 40. 5. Hepatitis B 6. TT (Tetanus Toxoid) 7. JE vaccination (in selected high disease burden districts) 8. Hib containing Pentavalent vaccine (DPT+HepB+Hib) (In selected States)
  • 41. Diseases covered under UIP 1. Diphtheria 2. Pertussis. 3. Tetanus 4. Polio 5. Tuberculosis
  • 42. 6. Measles 7. Hepatitis B 8. Japanese Encephalitis ( commonly known as brain fever) 9. Meningitis and Pneumonia caused by Haemophilus Influenzae type b
  • 43. Barriers to Immunization Physical barriers -Waiting time -Distance -Discomfort Psychological barriers -Discourtesy - Endangered privacy
  • 44. Reasons for Low Immunization Coverage  Failure to provide immunization  Un-reached populations:- - Unawareness - socio-economic barriers - geographic access  Resistant populations  Missed Opportunities  Improper logistics management
  • 45. What Should not Hold Routine Immunization  Minor illnesses such as upper respiratory infections or diarrhea, mild fever (< 38.5°c) Allergy, asthma Prematurity, underweight newborn child  Family history of convulsions
  • 46. Treatment with antibiotics  Dermatosis, eczema or localized skin infection  Chronic diseases of the heart, lung, kidney and liver.  Stable neurological conditions, such as cerebral palsy and Down's syndrome  History of jaundice after birth
  • 49. Cold Chain The ‘cold chain’ is the system of transporting and storing vaccines at recommended temperature from the point of manufacture to the point of use. Manufacturer Distributor Vaccine Depots Provider office Client
  • 50. Why is the cold chain important ? 1. Vaccines are:  Biological products  lose potency with time  Process irreversible and accelerated if proper storage conditions are not adhered to. 2. Assurance in potent product and vaccine programmes  Professional responsibility  Confident the vaccines you give will be effective  Public Health responsibility  Public confidence in immunisation programmes 3. Ensuring maximum benefit from immunisations Responsibility not to waste scarce NHS resources Reduce wastage from errors 4.Compliance with SPC/Manufacturer Any vaccine that has not been stored at a temperature of 2-8ºC as per its licensing conditions is no longer a licensed product
  • 51. Cold chain storage equipment Walk in cold rooms Deep freezers Ice lined refrigerators
  • 52. A. Walk in cold rooms(WIC) At regional level Storage up to 3 months Serve 4-5 districts
  • 53. B. Deep freezers  At district & PHC levels  Temp :- -15oc to -25oc  At PHC, used only for the preparation of ice packs  In case of power failure these freezers can maintain the cabinet temp. for 18-22 hours  20-25 icepack can be prepared by a 140L in deep freezers with continuous electric supply of 8 hours.
  • 54. C. Ice Lined Refrigerators(ILR)  Both at district and PHC levels  Temp :- +2oc to +8oc  ILR’s are top opening, can hold cold air inside better than front opening refrigerators  It can keep vaccine safe with 8 hours of continuous electric supply in a 24 hours period.
  • 55. Arrangement of vaccine order top to bottom: Hepatitis B DPT & TT BCG Measles OPV Discard any frozen hep.b, DPT, & TT. Keep spaces between boxes Measles & OPV can be kept over 2 rows of empty ice-packs on the floor of the ILR.
  • 56. Vaccine Stability  Sensitivity to HEAT OPV Measles BCG MMR Hepatitis B DT  Sensitivity to COLD HepB and combination Influenza *BCG (*Freeze dried) MOST SENSITIVE Temperature must be recorded twice in a day with dial thermometer LEAST SENSITIVE
  • 57. Light Sensitive Sensitive to strong light, sunlight, ultraviolet, fluorescents (neon) OPV Measles MMR Varicella Meningococcal C Conjugate Most DTaP containing vaccines Vaccines should always be stored in their original packaging until point of use to protect them from light
  • 58. Vaccine Storage  Use a dedicated vaccine fridge  Safeguard electricity supply  No more than 50% full  Place vaccines in clearly labelled plastic mesh baskets  Group vaccines by type (Paediatric, Adult, Adolescent)  Defrost/calibrate fridge regularly X No food or medical specimens X Do not place fridge in direct sunlight or near heat source X Do not store vaccines for more than 1 month at PHC. X Do not store vaccines in fridge doors or in solid plastic trays/containers within the fridge X Keep vaccines away from fridge walls and cold air vents Picture taken from www.medisave.co.uk DO’sDON’T’s
  • 60. Used for transport of vaccines Fully frozen ice packs placed at the bottom and sides DPT, TT, DT should not be kept in direct contact 1.Cold boxes Used to carry small quantity of vaccines(16 to 20 vials) For out of reach sessions 4 icepacks are used 2.Vaccine carriers
  • 61. 3.Day carriers Used to carry very small quantities of vaccines(6 to 8 vials) For a near by session 2 icepacks are used For only 2 hours period
  • 62. ICE PACKS It contains water & no salt shold be added to it. The water should be filled upto the level marked on the side. If there is leakage such icepack should be discarded.
  • 63. Vaccine Vial Monitor(VVM) VVM is a label containing heat sensitive material that is placed on a vaccine vial to register heat exposure over time Vaccine vial monitor
  • 64. Stage 1 • Inner square lighter than outer circle Stage 2 • Inner square still lighter than outer circle Stage 3 • Color of inner square matches the outer circle Stage 4 • Color of inner square darker than outer circle Combined effects of time and temperature cause the inner square to darken gradually and irreversibly VVM does not directly measure the vaccine potency but gives info about the main factor that affects potency
  • 68. Mission Indradhanush was launched by Ministry of Health and Family Welfare (MOHFW) Government of India on 25th December, 2014. The objective of this mission is to ensure that all children under the age of two years as well as pregnant women are fully immunized with seven vaccine preventable diseases.
  • 69. The Mission Indradhanush, depicting seven colours of the rainbow, targets to immunize all children against seven vaccine preventable diseases.
  • 71. Science Hopes a Vaccine for every Disease